PROM1 and prostate cancer: CD133 has been proposed to be a putative surface marker in a number of tumors, however Collins et al. [35] used this marker to identify the prostate cancer stem cell population, and reported for the first time the identification and characterization of a cancer stem cell population from human prostate tumors.